Hip replacement

Series
Orthopedics
Status
Published
Date
Number of report
064

Ask the expert

(we accept only company emails)

The report presents a summary of the reimbursement situation for total and partial hip replacement in Europe. The following indications will be considered:

  • coxarthrosis;
  • osteonecrosis.

The only reimbursement within public / statutory health insurance systems is considered.

The report includes essential information about reimbursement, including:

  • Brief country-specific overview of reimbursement system
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions on indications or scenarios for the use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • Finland
  • France
  • Germany
  • Italy
  • The Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for open hip replacement include:

  • Aimedic MMT
  • Altimed
  • Amplitude
  • Arzzt
  • B. Braun Medical
  • Beijing Chunlizhengda Medical Instruments
  • Beznoska
  • Biotech-Medical Group
  • Biotechni Orthopédie
  • C2F implants
  • Corentec
  • Corin
  • Dedienne Sante
  • DePuy Synthes
  • EgiFix
  • Elite surgical
  • Euros
  • Evolutis
  • Exactech
  • FH Orthopedics
  • Groupe Lépine
  • Imeco. Implantes Ortopédicos
  • JRI Orthopaedics
  • LimaCorporate
  • Marle Orthopaedics Manufacturing
  • Medacta Corporate
  • Meril
  • MicroPort
  • Ortho Development
  • Ortosintese
  • Peter Brehm
  • Smith & Nephew
  • Stryker
  • Surgival
  • Tst Tibbi Aletler San. Ve Tic. Ltd
  • X.NOV Medical Technology
  • Zimmer Biomet

Table of content is not available at the moment. Report is still ongoing.

13

Jun 2019

The report presents a summary of reimbursement situation for total and partial hip replacement in Europe. The following indications will be considered: coxarthrosis, osteonecrosis. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

27

Sep 2018

In mid-August 2018, the Catalan agency for quality and health evaluation, AQuAS, has published a report that presents the results of the knee prostheses made by Surgival, a Spanish protheses manufacturer. The report covers the period 2005-2016.

Read more

01

Aug 2018

The Clinical Coding and Schedule Development Group develops and maintains procedural and diagnostics nomenclature for private payers in England. In June, new codes for laparoscopic pelvic lymphadenectomy, robotic assisted total knee replacement, abdominal (mesenteric) and limb angiogram were added to the CCSD Schedule.

Read more

26

Mar 2018

The Clinical Coding and Schedule Development Group develops and maintains procedural and diagnostics nomenclature for private payers in England. In February new codes for preparation and delivery of radiotherapy, knee resurfacing arthroplasty, balloon dilatation of the Eustachian tube and MRI-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor were added to the CCSD Schedule.

Read more

07

Mar 2018

In February, HAS published a set of decisions about add-on reimbursement of medical devices that were evaluated by the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). These decisions concern cardiac pacemakers, devices for aortic root replacement, orthopedic devices (double mobility cups, porous high-density polyethylene implants) and other devices.

Read more

30

May 2017

AETSA aimed to establish recommendations for clinical practice on hip arthroplasty in patients with osteoarthritis through a systematic appraisal of evidence. High-level recommendations for hip arthroplasty and selection of type of implants were made.

Read more
(we accept only company emails)